By Stephanie Krenrich, Senior Vice President of Policy & Government Affairs, Advocates for Community Health As Congress considers its year-end agenda, Advocates for Community Health (ACH) is urging lawmakers to advance policies that strengthen community health centers and protect the care that nearly 34 million patients depend on. In our October 15 letter to congressional […]
Becker’s Hospital Review highlighted Advocates for Community Health’s support for the bipartisan 340B Rebate Model Delay Act, introduced by Representatives Rob Bresnahan (R-PA), Debbie Dingell (D-MI), Tracey Mann (R-KS), and Lois Frankel (D-FL). The legislation would preserve upfront 340B drug discounts and block implementation of the rebate pilot for two years, from January 1, 2027, […]
Legislation would preserve upfront drug discounts for two years while Congress considers comprehensive 340B reform. WASHINGTON, D.C., [October 9, 2026] — Advocates for Community Health (ACH) today welcomed the introduction of bipartisan legislation by Representatives Rob Bresnahan (R-PA), Debbie Dingell (D-MI), Tracey Mann (R-KS), and Lois Frankel (D-FL) to delay implementation of the 340B Rebate […]
Community Health Centers (CHCs), also called Federally Qualified Health Centers (FQHCs), may be our nation’s best health policy experiment, delivering a bold return on investment in the sixty years since their inception. Every $1 invested in primary care returns $13 in saved downstream costs. From urban areas to rural communities, CHCs play a crucial role […]
In response to the Health Resources & Services Administration (HRSA)’s publication yesterday of ten approved manufacturer plans for its revised 340B rebate pilot program set to take effect Jan. 1, 2027, ACH has issued the following statement: ACH is disgusted that HRSA is moving forward with the ill-advised 340B Rebate Model Pilot Program. Since this […]
Johnson & Johnson will begin requiring 340B-covered entities, including community health centers, to submit claims-level data to maintain access to upfront 340B discounts. The new policy, which takes effect Sept. 15, requires detailed prescription, provider and pharmacy information generally within 45 days of dispensing. Providers that fail to submit timely and complete data could ultimately […]
Johnson & Johnson’s new 340B claims-data policy, effective September 15, will require community health centers and other covered entities to submit extensive claims information whenever a discounted J&J product is dispensed. In an interview with Inside Health Policy, ACH CEO Amanda Pears Kelly warned that the requirement will impose significant administrative and financial burdens on […]
In response to the bipartisan Senate 340B “Gang of Six” working group’s introduction of the SUSTAIN 340B Act on August 5, 2026, Advocates for Community Health (ACH) issued the following statement: “ACH is grateful to Sens. Baldwin (D-WI), Boozman (R-AR), Capito (R-WV), Hickenlooper (D-CO), Kaine (D-VA), and Moran (R-KS) for their leadership to craft comprehensive […]
On July 31, the Health Resources and Services Administration (HRSA) unveiled a new 340B rebate model pilot, triggering immediate reactions across the healthcare sector regarding its potential impact on safety-net providers. The new model which begins January 1, 2027, would change the long-standing program that offers upfront discounts with a new, post-purchase rebate system. While […]
Bloomberg Government reported today that the U.S. Department of Health and Human Services will implement a revised 340B rebate pilot beginning Jan. 1, 2027. The model will require health centers and other covered entities to pay full price for certain drugs and later seek rebates, raising serious concerns about cash-flow disruptions, administrative burdens and the […]
